Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct;37(10):1353–1362. doi: 10.1177/08850666221103495

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

PMC Copyright notice

Figure 2. — Comparison of the survival of the patients in terms of the presence of ICU-acquired BSI. Survival of the ICU patients with COVID-19 was analyzed via the Kaplan-Meier method. Solid line presents the survival of the patients with ICU-acquired BSI, and dotted line presents those without ICU acquired BSI. Right censoring was the discharge from the ICU. The maximum follow-up period was 38 days in the patients with ICU-acquired BSI and 78 days in the patients without ICU-acquired BSI. The origin of follow-up period started on the first day of ICU admission for the patients did not develop ICU-acquired BSI, and the first day of the first ICU-acquired BSI episode for the patients developed ICU-acquired BSI.